Download PDFPDF
Old ways, new means: tobacco industry funding of academic and private sector scientists since the Master Settlement Agreement
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

  • Published on:
    ERRATUM for “Old ways, new means: tobacco industry funding of academic and private sector scientist

    The published paper (p. 158) says "From 2002 to 2004, the IFSH granted US$3.9 million to academic scientists studying biomarkers of tobacco-smoke exposure and harm, tobacco harm reduction and toxicity of tobacco constituents”. The correct number for this time period is $2.9 million. As of August, 2007 the nonprofit Institute for Science and Health had spent US$3.83 million on tobacco industry funded research and US$12...

    Show More
    Conflict of Interest:
    None declared.